Nail changes in patients with inflammatory bowel diseases

Nail changes in patients with inflammatory bowel diseases

Background/aim: Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. To our knowledge, no studies to date pertain to the profile of nail changes in IBD, except for onychomycosis. We aimed to study the frequency and pattern of nail changes among patients with IBD and evaluate their potential relationships with several parameters in IBD. Materials and methods: The study included 73 patients with IBD and 51 healthy control subjects. Nails of both groups were examined for changes with regard to color, striations, texture, curvature of nail plates, dystrophy of nail plates, and pigmentation. Mycological examinations were performed when onychomycosis was suspected. Results: Nail changes were statistically higher in patients with IBD than in the control group (P = 0.001). The presence of onychomycosis was significantly more common in patients with IBD (P = 0.041). Subungual hyperkeratosis and brownish discoloration of the nail were the most common findings in patients with IBD. Conclusion: Our study is the first report showing all nail changes in IBD. Further studies with more subjects are needed to reveal more detailed information about nail changes in IBD.

___

  • 1. Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am Fam Physician 2004; 69: 1417–1424.
  • 2. Lashner B. Inflammatory bowel disease. In: Carey WD, editor. Cleveland Clinic: Current Clinical Medicine. Philadelphia, PA, USA: Saunders; 2009.
  • 3. Ertürk M. Epidemiological features of our patients with ulcerative colitis. J Clin Anal Med 2013; 4: 13–15.
  • 4. Thrash B, Patel M, Shah KR, Boland CR, Menter A. Cutaneous manifestations of gastrointestinal disease: Part II. J Am Acad Dermatol 2013; 68: 211.e3–211.e33.
  • 5. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005; 11: 7227–7236.
  • 6. Károlyi Z, Erós N, Ujszászy L, Nagy G. Cutaneous and mucosal manifestations of inflammatory bowel diseases. Orv Hetil 2000; 141: 1391–1395 (in Polish with abstract in English).
  • 7. Itin PH, Rufli T. Skin symptoms in gastrointestinal diseases. Ther Umsch 1995; 52: 236–242 (in German with abstract in English).
  • 8. Areias E, Garcia e Silva L. Cutaneous manifestations of ulcerative colitis. Med Cutan Ibero Lat Am 1987; 15: 185–197 (in Portuguese with abstract in English).
  • 9. Paller AS. Cutaneous changes associated with inflammatory bowel disease. Pediatr Dermatol 1986; 3: 439–445.
  • 10. Burgdorf W. Cutaneous manifestations of Crohn’s disease. J Am Acad Dermatol 1981; 5: 689–695.
  • 11. Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease. Aliment Pharm Therap 2004; 20: 50–53.
  • 12. Allan RN. Extra-intestinal manifestations of inflammatory bowel disease. Clin Gastroenterol 1983; 12: 617–632.
  • 13. Gaburri D, Chebli JM, Zanine A, Gamonal AC, Gaburri PD. Onychomycosis in inflammatory bowel diseases. J Eur Acad Dermatol 2008; 22: 807–812.
  • 14. Tunc SE, Ertam I, Pirildar T, Turk T, Ozturk M, Doganavsargil E. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis? J Eur Acad Dermatol 2007; 21: 497–503.
  • 15. Gupta AK, Ricci MJ. Diagnosing onychomycosis. Dermatol Clin 2006; 24: 365–369.
  • 16. de Berker D. Fungal nail disease. New Engl J Med 2009; 360: 2108–2116.
  • 17. Surjushe A, Kamath R, Oberai C, Saple D, Thakre M, Dharmshale S, Gohil A. A clinical and mycological study of onychomycosis in HIV infection. Indian J Dermatol Venereol Leprol 2007; 73: 397–401.
  • 18. Schons KR,  Knob CF,  Murussi N,  Beber AA,  Neumaier W, Monticielo OA. Nail psoriasis: a review of the literature. An Bras Dermatol 2014; 89: 312–317.
  • 19. Baran R. The nail in the elderly. Clin Dermatol 2011; 29: 54–60.
  • 20. Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol  2011; 65: 1219– 1227.
  • 21. Zaiac MN,  Walker A. Nail  abnormalities associated with systemic pathologies. Clin Dermatol 2013; 31: 627–649.
  • 22. Nicolopoulos J, Goodman GJ, Howard A. Diseases of the generative nail apparatus. Part I: Nail matrix. Australas J Dermatol 2001; 43: 81–90.
  • 23. Scher RK, Daniel CR. Nails: Therapy, Diagnosis, Surgery. Philadelphia, PA, USA: Saunders; 1990.
  • 24. Cashman MW,  Sloan SB. Nutrition  and  nail disease. Clin Dermatol 2010; 28: 420–425.
  • 25. Holzberg M. Nail signs of systemic disease. In: Hordinsky MK, Sawaya ME, Scher RK, editors. Atlas of Hair and Nails. Philadelphia, PA, USA: Churchill Livingstone; 2000. pp. 59–70.
  • 26. Baran R, Tosti A. Nails. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick’s Dermatology in General Medicine. 6th ed. New York, NY, USA: McGraw-Hill; 2003. pp. 656–671.
  • 27. Saray Y, Seçkin D, Güleç AT, Akgün S, Haberal M. Nail disorders in hemodialysis patients and renal transplant recipients: a casecontrol study. J Am Acad Dermatol 2004; 50: 197–202.
  • 28. Salem A, Al Mokadem S, Attwa E, Abd El Raoof S, Ebrahim HM, Faheem KT. Nail changes in chronic renal failure patients under haemodialysis. J Eur Acad Dermatol 2008; 22: 1326– 1331.
  • 29. Zágoni T, Sipos F, Tarján Z, Péter Z. The half-and half nail: a new sign of Crohn’s disease? Report of four cases. Dis Colon Rectum 2006; 49: 1071–1073.
  • 30. Pellegrino M,  Taddeucci P,  Mei S,  Peccianti C,  Fimiani M. Half-and-half nail in a patient with Crohn’s disease. J Eur Acad Dermatol 2010; 24: 1366–13
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

The protective effect of Capparis ovata in acute hepatotoxicity induced by paracetamol

Tuğba KOCA, Mustafa AKÇAM, Meltem ÖZGÖÇMEN, Nurcan DOGAN, Duygu KUMBUL DOĞUÇ

Nail changes in patients with inflammatory bowel diseases

Mehmet DEMİR, Ebru ÇELİK, Fuat EKİZ, Ömer BAŞAR, İlknur BALTA, Özlem EKİZ, Emine Nur RİFAİOĞLU, Bilge BÜLBÜL ŞEN, Osman YÜKSEL

Total white blood cell count, liver enzymes, and metabolic syndrome in schizophrenia

Ali ÇAYKÖYLÜ, Görkem KARAKAŞ UĞURLU, Mustafa UĞURLU, Semra ULUSOY KAYMAK, Sibel ÖRSEL

Özgür BALTA, Uğur ACAR, Fatma Akbaş KOCAOĞLU, Firdevs ÖRNEK

Levent DALAR, Seda Tural ÖNÜR, Cengiz ÖZDEMİR, Sinem Nedime SÖKÜCÜ, Ahmet Levent KARASULU, Sedat ALTIN

Does the course of laboratory parameters help us to predict the outcome of CCHF?

Esragül AKINCI, Hurrem BODUR, Bircan KAYAASLAN, Aliye BAŞTUĞ, Selim Sırrı EREN, Sümeyye KAZANCIOĞLU, Halide ASLANER, Ayşe BUT, Meltem Arzu YETKİN

Nilüfer GÜZOĞLU, Ümit Ayşe TANDIRCIOĞLU, Didem ALİEFENDİOĞLU

Mehmet PARLAK, Aytekin ÇIKMAN, Yasemin BAYRAM, Nesrin CEYLAN, Ulaş ÇALIŞIR, Mustafa BERKTAŞ

Initial Experience with Delivery of Palliative Care to Terminal Cancer Patients

Serkan DOĞRU, Serkan KARAMAN, Tuğba KARAMAN, Mehmet ESEN, Mustafa SÜREN, İsmail OKAN, Mevlüt ÇÖMLEKÇİ, Ziya KAYA, Aynur ŞAHİN, Semih ARICI, Murat AYAN

The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of response to fixed-dose peptide receptor radionuclide therapy with Lu-177 DOTATATE

Metin Kemal KIR, Özlem Nuriye KÜÇÜK, Çiğdem SOYDAL, Ahmet PEKER, Elgin ÖZKAN